PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:31 AM ET

Sponsor Check › Person

MR
No photo found yet (own website and image search run after this page is viewed)

Michael Rome

Named as an officer, director or promoter on SEC Form D filings · CA · Dec 23, 2019 → Mar 26, 2024

4deals (issuers)
$708.4Mreported sold
86investors
8Form D filings
2019–2024years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:45 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Michael Rome is listed as a director on 8 SEC Form D filings by 4 issuers between Dec 2019 and Mar 2024: Avenzo Therapeutics, Inc. (San Diego, CA — biotechnology — 2022–2024; $385.9M reported sold to 22 investors), ALUMIS INC. (South San Francisco, CA — biotechnology — 2021; $129.5M reported sold to 24 investors), Kinnate Biopharma Inc. (San Diego, CA — biotechnology — 2019–2020; $98M reported sold to 24 investors) and Theseus Pharmaceuticals, Inc. (Cambridge, MA — pharmaceuticals — 2021; $95.1M reported sold to 16 investors).

What this means A repeat sponsor — 4 separate companies raised money with this person listed as director, over about 5 years. Across those companies the filings report $708.4M sold in total.

Listed alongside Carl L. Gordon (7 shared filings), Stephen W. Kaldor (3 shared filings), Athena Countouriotis (2 shared filings), Brian Sun (2 shared filings), Iain Dukes (2 shared filings) and 16 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Michael. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 10 bankruptcy cases matching the name listed in Key records below.

What this means 10 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 8 public filings for Michael Rome and found 9 differences, 1 worth asking the sponsor about: Michael Rome is no longer listed on the Nov 20, 2024 amendment; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Michael Rome has not run yet — it is joining a line of 17,971 names; searches run around the clock at the hosts' allowed rate. Searched so far: 28 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:45 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Michael Rome..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

10 cases: 1 open, 9 closed (disposition not in docket feed)

Michael G. Rome and Sharon B. Rome open
United States Bankruptcy Court, S.D. Mississippi · No. 21-50987 · Filed Sep 17, 2021
Role of Michael G. Rome and Sharon B. Rome: Debtor · Outcome: Open — no termination date on the docket (bulk snapshot 2026-09-30) Docket on CourtListener ↗
same full name (a name found in 16 federal dockets); 4 people with this name in Form D filings; court in MS (not a filing state)
Michael S. Rome and Bettina P. Rome closed
United States Bankruptcy Court, M.D. Florida · No. 3:17-bk-03077 · Filed Aug 22, 2017 · Closed Aug 17, 2020
Role of Michael S. Rome and Bettina P. Rome: Debtor · Outcome: Case closed 2020-08-17 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 16 federal dockets); 4 people with this name in Form D filings; court in FL (not a filing state)
Michael S. Rome closed
United States Bankruptcy Court, M.D. Florida · No. 8:14-bk-14964 · Filed Dec 29, 2014 · Closed Apr 3, 2015
Role of Michael S. Rome: Debtor · Outcome: Case closed 2015-04-03 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 16 federal dockets); 4 people with this name in Form D filings; court in FL (not a filing state)
MICHAEL J. ROME closed
United States Bankruptcy Court, D. Nevada · No. 12-12764 · Filed Mar 12, 2012 · Closed Jun 18, 2012
Role of MICHAEL J. ROME: Debtor · Outcome: Case closed 2012-06-18 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 16 federal dockets); 4 people with this name in Form D filings; court in NV (not a filing state)
Michael S. Rome closed
United States Bankruptcy Court, D. Colorado · No. 03-23833 · Filed Jul 17, 2003 · Closed Nov 14, 2003
Role of Michael S. Rome: Debtor · Outcome: Case closed 2003-11-14 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 16 federal dockets); 4 people with this name in Form D filings; court in CO (not a filing state)
Michael O. Rome and Carol L. Rome closed
United States Bankruptcy Court, D. New Jersey · No. 00-31740 · Filed Feb 23, 2000 · Closed Jun 12, 2000
Role of Michael O. Rome and Carol L. Rome: Debtor · Outcome: Case closed 2000-06-12 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 16 federal dockets); 4 people with this name in Form D filings; court in NJ (not a filing state)
Michael A. Rome closed
United States Bankruptcy Court, D. Kansas · No. 97-40999 · Filed Apr 17, 1997 · Closed Jan 13, 1999
Role of Michael A. Rome: Debtor · Outcome: Case closed 1999-01-13 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 16 federal dockets); 4 people with this name in Form D filings; court in KS (not a filing state)
Michael A. Rome closed
United States Bankruptcy Court, N.D. Georgia · No. 96-68112 · Filed May 23, 1996 · Closed Sep 11, 1996
Role of Michael A. Rome: Debtor · Outcome: Case closed 1996-09-11 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 16 federal dockets); 4 people with this name in Form D filings; court in GA (not a filing state)
Michael Rome closed
United States Bankruptcy Court, E.D. Wisconsin · No. 94-23748 · Filed Jul 18, 1994 · Closed Oct 26, 1994
Role of Michael Rome: Debtor · Outcome: Case closed 1994-10-26 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 16 federal dockets); 4 people with this name in Form D filings; court in WI (not a filing state)
Michael L. Rome closed
United States Bankruptcy Court, D. Connecticut · No. 89-20312 · Filed Mar 20, 1989 · Closed Mar 14, 1990
Role of Michael L. Rome: Debtor · Outcome: Case closed 1990-03-14 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 16 federal dockets); 4 people with this name in Form D filings; court in CT (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:45 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

9 differences found between the filings for Michael Rome — 1 worth asking about (compared 8 filings on Oct 24, 2026)

Worth asking · Mar 26, 2024 – Nov 20, 2024

Michael Rome is no longer listed on the Nov 20, 2024 amendment — Avenzo Therapeutics, Inc.

Michael Rome appears on the Mar 26, 2024 Form D/A (director) but not on the Nov 20, 2024 Form D/A for the same offering.

What this means People leave, and the issuer must list only current officers, directors and promoters. It is still worth asking why this person left and who replaced them.

Sources
Note · Jun 29, 2018 – Nov 20, 2024

4 offerings changed their target amount between filings

Offering amount changed between filings — Avenzo Therapeutics, Inc. · Offering amount changed between filings — Avenzo Therapeutics, Inc. · Offering amount changed between filings — Theseus Pharmaceuticals, Inc. · Offering amount changed between filings — Kinnate Biopharma Inc.

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Sources
Note · Jan 22, 2021 – Feb 4, 2021

No amendment in the last 12 months on an offering that may still be open — Theseus Pharmaceuticals, Inc. (latest filing Feb 4, 2021)

The latest filing for this offering is dated Feb 4, 2021 (first sale Jan 22, 2021). It reports $95,099,957 sold of $100,099,954 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Jun 29, 2018 – Feb 4, 2021

Industry group changed between filings — Theseus Pharmaceuticals, Inc.

"Other Technology" (Jun 29, 2018); then "Pharmaceuticals" (Feb 4, 2021 to Feb 4, 2021).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Sources
Note · Dec 23, 2019 – Aug 4, 2020

Industry group changed between filings — Kinnate Biopharma Inc.

"Pharmaceuticals" (Dec 23, 2019); then "Biotechnology" (Aug 4, 2020 to Aug 31, 2020).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Sources
Note · Jan 16, 2018 – Dec 31, 2025

Same name, different state: "Michael Rome" (FL) is a separate record

This page covers filings where the address state is CA. A separate record, "Michael Rome" with address state FL, is listed on 9 filings — most recently by Rome Capital Investors Offshore Ltd. (Dec 31, 2025). Both records have filings in the same period (Dec 23, 2019 to Mar 26, 2024).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Jan 4, 2024

Same name, different state: "Michael Rome" (MA) is a separate record

This page covers filings where the address state is CA. A separate record, "Michael Rome" with address state MA, is listed on 1 filing — most recently by Remix Therapeutics, Inc. (Jan 4, 2024). Both records have filings in the same period (Jan 4, 2024).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Jan 10, 2014 – Jan 30, 2015

Same name, different state: "Michael Rome" (NY) is a separate record

This page covers filings where the address state is CA. A separate record, "Michael Rome" with address state NY, is listed on 6 filings — most recently by Seaview Offshore Fund Ltd. (Jan 30, 2015). The two records do not overlap in time: this page runs Dec 23, 2019 to Mar 26, 2024; the other runs Jan 10, 2014 to Jan 30, 2015.

What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Jun 29, 2018 – Feb 4, 2021

Address moved from New York, NY to Cambridge, MA — Theseus Pharmaceuticals, Inc.

The people listed on the Jun 29, 2018 filing give New York, NY; on the Feb 4, 2021 filing they give Cambridge, MA. The address now on file (210 Broadway, Suite 201, Cambridge, MA) is a registered-agent or shared-office address used by 8 issuers.

What this means A registered agent's address is a mailbox, not where the team works. Ask where the business actually operates.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

None reported on 6 offerings — no sales commissions, finder's fees or proceeds to insiders

Per-offering detail
Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Mar 26, 2024 D/A
Avenzo Therapeutics, Inc.
File 021-460216
$0$0$0None listed on this filingEDGAR ↗
Mar 19, 2021 D
ALUMIS INC.
File 021-392889
$0$0$0None listed on this filingEDGAR ↗
Feb 4, 2021 D/A
Theseus Pharmaceuticals, Inc.
File 021-315789
$0$0$0None listed on this filingEDGAR ↗
Feb 4, 2021 D
Theseus Pharmaceuticals, Inc.
File 021-388439
$0$0$0None listed on this filingEDGAR ↗
Aug 31, 2020 D/A
Kinnate Biopharma Inc.
File 021-372487
$0$0$0None listed on this filingEDGAR ↗
Dec 23, 2019 D
Kinnate Biopharma Inc.
File 021-356223
$0$0$0None listed on this filingEDGAR ↗

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 4

Every issuer that named Michael Rome on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Biotechnology

Avenzo Therapeutics, Inc.

San Diego, CA · Sep 29, 2022 → Mar 26, 2024 · 2 filings
  • Mar 26, 2024 · D/A · $223,350,002 sold of $346,850,003 · 19 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 29, 2022 · D · $31,499,999 sold of $171,500,004 · 6 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $385.9M from 22 investors (100% of the $346.9M target) as of the latest filing. Michael is listed as director on 2 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other Health Care

ALUMIS INC.

South San Francisco, CA · Mar 19, 2021
  • Mar 19, 2021 · D · $60,000,000 sold of $60,000,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $129.5M from 24 investors (100% of the $60M target) as of the latest filing. Michael is listed as director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pharmaceuticals

Theseus Pharmaceuticals, Inc.

Cambridge, MA · Feb 4, 2021 → Feb 4, 2021 · 2 filings
  • Feb 4, 2021 · D · $95,099,957 sold of $100,099,954 · 16 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 4, 2021 · D/A · $22,136,987 sold of $22,136,987 · 3 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $95.1M from 16 investors (95% of the $100.1M target) as of the latest filing. Michael is listed as director on 2 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

Kinnate Biopharma Inc.

San Diego, CA · Dec 23, 2019 → Aug 31, 2020 · 3 filings
  • Aug 31, 2020 · D/A · $97,999,937 sold of $97,999,937 · 24 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 4, 2020 · D · $87,999,943 sold of $87,999,943 · 22 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 23, 2019 · D · $74,499,991 sold of $74,499,991 · 5 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $98M from 24 investors (100% of the $98M target) as of the latest filing. Michael is listed as director on 3 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other pages with the same name (3)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Michael Rome — NY, 2 issuers, Jan 10, 2014 → Jan 30, 2015 · no shared issuer
  • Michael Rome — FL, 1 issuer, Jan 16, 2018 → Dec 31, 2025 · no shared issuer
  • Michael Rome — MA, 1 issuer, Jan 4, 2024 → Jan 4, 2024 · no shared issuer

People around Michael 21

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Carl L. Gordon

Director · 7 shared filings (3 issuers) · also on 59 other issuers

Carl L. Gordon is on 62 issuers in total — a repeat sponsor. Their page lists every one.

SK
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen W. Kaldor

Executive Officer, Director, Promoter · 3 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Michael Rome. Their page shows their other deals.

SG
No photo found yet (own website and image search run after this page is viewed)
Person

Simeon George

Director · 2 shared filings (1 issuer) · also on 32 other issuers

Simeon George is on 33 issuers in total — a repeat sponsor. Their page lists every one.

AC
No photo found yet (own website and image search run after this page is viewed)
Person

Athena Countouriotis

Executive Officer, Director · 2 shared filings (1 issuer) · also on 4 other issuers

Athena Countouriotis is on 5 issuers in total — a repeat sponsor. Their page lists every one.

JT
No photo found yet (own website and image search run after this page is viewed)
Person

Jim Tananbaum

Director · 2 shared filings (1 issuer) · also on 5 other issuers

Jim Tananbaum is on 6 issuers in total — a repeat sponsor. Their page lists every one.

KF
No photo found yet (own website and image search run after this page is viewed)
Person

Keith Flaherty

Director · 2 shared filings (1 issuer)

Listed on the same filings as Michael Rome. Their page shows their other deals.

MM
No photo found yet (own website and image search run after this page is viewed)
Person

Mark Meltz

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Michael Rome. Their page shows their other deals.

ID
No photo found yet (own website and image search run after this page is viewed)
Person

Iain Dukes

Executive Officer, Director · 2 shared filings (1 issuer) · also on 4 other issuers

Iain Dukes is on 5 issuers in total — a repeat sponsor. Their page lists every one.

WS
No photo found yet (own website and image search run after this page is viewed)
Person

William C. Shakespeare

Director · 2 shared filings (1 issuer)

Listed on the same filings as Michael Rome. Their page shows their other deals.

BS
No photo found yet (own website and image search run after this page is viewed)
Person

Brian Sun

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Michael Rome. Their page shows their other deals.

MH
No photo found yet (own website and image search run after this page is viewed)
Person

Mohammad Hirmand

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Michael Rome. Their page shows their other deals.

NF
No photo found yet (own website and image search run after this page is viewed)
Person

Nima Farzan

Executive Officer, Director · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Michael Rome. Their page shows their other deals.

DM
No photo found yet (own website and image search run after this page is viewed)
Person

Dean Mitchell

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Michael Rome. Their page shows their other deals.

JT
No photo found yet (own website and image search run after this page is viewed)
Person

James B. Tananbaum

Director · 1 shared filing (1 issuer) · also on 28 other issuers

James B. Tananbaum is on 29 issuers in total — a repeat sponsor. Their page lists every one.

JL
No photo found yet (own website and image search run after this page is viewed)
Person

Judith Li

Director · 1 shared filing (1 issuer) · also on 5 other issuers

Judith Li is on 6 issuers in total — a repeat sponsor. Their page lists every one.

EM
No photo found yet (own website and image search run after this page is viewed)
Person

Eric Murphy

Executive Officer, Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Michael Rome. Their page shows their other deals.

BZ
No photo found yet (own website and image search run after this page is viewed)
Person

Bret Zbar

Director · 1 shared filing (1 issuer)

Listed on the same filings as Michael Rome. Their page shows their other deals.

LA
No photo found yet (own website and image search run after this page is viewed)
Person

Laurie Smaldone Alsup

Director · 1 shared filing (1 issuer)

Listed on the same filings as Michael Rome. Their page shows their other deals.

JL
No photo found yet (own website and image search run after this page is viewed)
Person

June Lee

Executive Officer, Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Michael Rome. Their page shows their other deals.

PT
No photo found yet (own website and image search run after this page is viewed)
Person

Paolo Tombesi

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Michael Rome. Their page shows their other deals.

SL
No photo found yet (own website and image search run after this page is viewed)
Person

Scott Lipman

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Michael Rome. Their page shows their other deals.

The team behind the deals

Same business address

21 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 4 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Michael Rome by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 4 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Michael Rome is listed on: none on file. No website or social profile named in Kinnate Biopharma Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #211,055 of 374,652 in line (16 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (San Diego, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Michael Rome appears on a new Form D, or when a court case or SEC action is matched to them. See plans →